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SUMMARY
A survey was carried out in two goat herds during a single peste des petits ruminant (PPR)
outbreak. Clinical examination showed that animals belonging to the West African Dwarf species
had severe symptoms while those belonging to the West African long-legged species had mild
symptoms. To conﬁrm and to monitor the disease in each species, the study required speciﬁc
monoclonal antibody-based diagnostic tools. An association of shedding of PPR virus (PPRV)
and acute or mild clinical signs of the disease could be demonstrated by the rinderpest virus
(RPV)/PPRV immunocapture ELISA assay. Between 85 and 100% of nasal secretions obtained
from clinically diseased goats during the PPR outbreak reacted positively. Parallel serological
surveillance for speciﬁc measurement of PPR antibodies revealed that between 34.4 and 88.5% of
animals with no detectable virus were, however, able to seroconvert and therefore seemed to
demonstrate that PPR subclinical infections do occur. Antibodies were shown to impair the RP
heterologous vaccination. This evaluation oﬀers new prospects for diagnosis and management of
PPRV infection as well as for RPV control.
INTRODUCTION
Peste des petits ruminants (PPR) is an important
pathogen of small ruminants in Africa, the Middle
East and India. PPR virus (PPRV) mainly causes
disease in sheep and goats, but it also causes sub-
clinical infection in cattle with the development of
a cross-neutralizing [1] and cross-protective [2, 3]
humoral response against rinderpest (RP). The usual
form of PPR is acute or subacute. PPR is charac-
terized by fever, erosive stomatitis, conjunctivitis,
gastroenteritis and pneumonia. These signs are not
found together and non-clinical infections can be
recorded for PPR as is the case for RP in cattle. It is
not known if this is a result of infection with diﬀerent
strains of virus or a variation in the sensitivity of
diﬀerent breeds. Study of the epidemiology of PPR in
small ruminants is further complicated by the use of
a heterologous RP tissue, culture-attenuated vaccine
for PPR prophylaxis in several African countries and
in India.
The infection is usually conﬁrmed by serology.
Various techniques have been applied in the past, but
only one, the virus neutralizing test (VNT) appears
to distinguish between PPR and RPV serum anti-
bodies [4]. The recent development of monoclonal
antibody (mAb)-based ELISAs has allowed the rapid
and simple diﬀerential diagnosis of RP and PPR.
Competitive ELISA (C-ELISA) are used for speciﬁc
detection of PPR or RP antibodies [5–7]. A deﬁnitive
diagnosis is made by isolation of the virus, but this
remains especially diﬃcult for PPRV and other
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Morbilliviruses. As an alternative to isolation, antigen
detection by immunocapture ELISA (ICE) is now
also possible [8].
In this investigation we studied an outbreak of PPR
in two breeds of goat. We found that ICE was reliable
and useful for disease conﬁrmation and monitoring
under ﬁeld conditions. The sensitivity and the speci-
ﬁcity of the test were established in relation to the
clinical diagnosis of the disease or the presence of
speciﬁc antibodies. Serological surveillance for PPR
antibodies revealed that PPR subclinical infections
can occur in small ruminants. The value of RP vacci-
nation during infection was also tested.
MATERIAL AND METHODS
Animals
The PPR outbreak occurred during the rainy
season in a goat population housed in the Institut
Se´ne´galais de Recherche Agricoles (ISRA) Dakar,
Se´ne´gal. For 2 weeks shed no. 1 housed 41 West
African dwarf (WAD) goats originating from the
South of the country. Thirty-one West African long-
legged (WALL) goats were housed in shed no. 2. The
groups lived in separated buildings and were always
kept indoors. Nutritional and hygienic conditions
were good.
When signs of the disease were observed, the
aﬀected animals and all the neighbouring small
ruminants were given the heterologous RP tissue,
culture-attenuated vaccine. This is a common practice
in West African countries, with the aim of stopping
the spread of the disease and limiting mortality.
Collection and processing of the samples
From the onset of the outbreak, goats were observed
on a daily basis to identify animals suspected of being
clinically diseased and to record mortality. They were
then observed on a weekly basis over 4 weeks to
monitor the excretion of the virus and seroconversion.
During this time, nasal, ocular or oral secretions and
serum were sampled. Samples of nasal secretion were
obtained with cotton swabs, which were broken oﬀ in
a sterile tube and kept on ice for transportation. Once
at the laboratory, the sample was expressed from the
cottonwool bud and tested with the ICE test. Serum
samples were frozen at x20 xC before testing. For
some animals, post-mortem samples were also exam-
ined. They included spleen, lung and mesenteric
lymph nodes. The autopsy specimens were stored at
x80 xC before further isolation.
Study design and statistics
To assess the reliability of the ICE test under ﬁeld
conditions, the assay response rate among disease and
seroconversion groups was compared. Goats with
acute or mild clinical signs were considered ‘disease
cases ’ and goats without either sign were ‘non-cases ’.
All available secreta and tissue samples obtained from
goats were tested by ICE, whereas the corresponding
sera from the same animal and from the same week of
sampling were submitted to PPR C-ELISA for the
presence of antibodies against the nucleoprotein of
the virus. Four patterns of disease and seroconversion
were expected in goats : disease-positive/seroconver-
sion-positive, disease-positive/seroconversion-nega-
tive, disease-negative/seroconversion-positive and
disease-negative/seroconversion-negative. Estimates
of sensitivity and speciﬁcity for ICE test were calcu-
lated [9] using the two diﬀerent deﬁnitions of clinical
PPR diagnosis : clinical disease status, and sero-
conversion status. Two group comparisons between
diseased and antigen-positive animals were made
using the x2 test at a=0.05.
The same assay was used for the conﬁrmation of
the clinically suspected outbreak and the monitoring
of the vaccinated animals. Each serum sample col-
lected from goats was also processed for the presence
of RP anti-haemagglutinin antibodies with H1 mAb
C-ELISA [5] to evaluate the interaction of PPR
infection on heterologous vaccination.
Virus isolation
The virus obtained during the epidemic was isolated
from the lung of a diseased animal. Vero cells were
inoculated with 100 ml of the specimen homogenate
supernatant. Cells were maintained in Eagle’s
Minimum Essential Medium containing 2% fetal calf
serum and antibiotics (40 mg gentamicin, 2.5 mg/ml
amphotericin G, 100 mg/ml streptomycin sulphate).
The medium was changed every 2 days and blind
passages carried out once a week. The ﬁrst cytopathic
eﬀects were observed 3 weeks after inoculation.
C-ELISA
The C-ELISAs for the detection of antibodies against
RP (provided courtesy of J. Anderson) and PPR were
based on similar protocols [5, 7]. Brieﬂy, Nunc
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Maxisorb 96-well plates were used. They were coated
with antigen diluted in PBS. After absorption and a
cycle of three washes in 1:5 diluted PBS, the sera were
incubated simultaneously with the speciﬁc mAb with
blocking buﬀer containing Tween-20 and serum. The
mAb was detected using rabbit anti-mouse enzyme-
conjugated immunoglobulin. Reaction with the
chromogen produced a colorimetric response, which
was measured using a Titertek Multiskan Photometer
(Labsystems, Helsinki, Finland) ELISA reader at
492 nm. Optical density (OD) values were converted
to percentage inhibition values (PI) using the
following formula:
PI=100x(OD test=OD 0% control)r100:
ICE test
The ICE test, produced as a kit, is based on a sand-
wich ELISA principle using couples of mAb. The
method described by Libeau and others [8] was fol-
lowed. In brief, Nunc Maxisorb plates were coated
with anti-RP and PPR cross-reactive mAb diluted in
PBS as a capture antibody. PPR or RP antigens were
detected with speciﬁc biotinylated mAbs in samples
incubated in duplicate on plates. The conjugate was
streptavidin peroxidase. Reaction with the chrom-
ogen mixture, hydrogen peroxide and orthophenylene
diamine, produced a colorimetric response signifying
a positive test.
RESULTS
Animals
Records for this study began with the onset of the
disease. The disease ﬁrst occurred in shed no. 1 where
WAD goats originating from South Senegal were
introduced for quarantine. They showed acute signs
of PPR: fever, cough, respiratory distress, visible
mouth lesions, mucopurulent oral and nasal dis-
charges, diarrhoea and rapid death. Because of their
high suseceptibility to PPRV, 25 animals out of 41
were recorded with disease on the ﬁrst day of the in-
vestigation. In the same week, the WALL goats from
shed no. 2 began to display clinical signs but in a very
mild form. All the animals in this group, except one,
survived. These goats had been living inside the lab-
oratory enclosure for several months without any
problem until the WAD group introduced the disease.
Survey for PPR infection in two goat species
To evaluate the inﬂuence of PPR infection on the goat
species, disease and serological survey as well as
antigen detection and virus isolation were conducted
on samples taken from the WAD andWALL goats at
intervals after natural infection. These results are
summarized in Table 1. In shed no. 1, in which the
WAD goats were kept, PPRV was detected from
swabs by ICE on day 1 in 21 out of 25 animals which
had clinical signs of PPR infection. However, none of
them excreted the virus for more than 1 week. A high
prevalence of antibodies against PPRV was also
detected by PPR C-ELISA (96–100%). Nevertheless,
14 animals died demonstrating that elimination of
PPRV does not prevent fatal after-eﬀects, such as
pneumonia [10]. From the autopsy specimen collected
from one WAD goat (the lung) it was possible to
isolate the virus after four blind passages on Vero
cells. The strain was later shown to belong to lineage
I, as are most strains from western Africa (data not
shown).
Table 1. Results of serological and virological survey for PPR disease conducted in two groups of goats
Shed
no. Day
No. of animals
PPR serology (%)
Virology
Surviving Diseased ICE* Virus isolation
1 1 25 25 24 (96) 21
+7 17 17 17 (100) 0
14 15 15 15 (100) 0
22 11 11 11 (100) 0
2 1 31 1 9 (29) 2
x7 30 2 10 (33
.3) 5
14 30 1 17 (56.7) 3
22 30 0 17 (56.7) 0
* Nasal secretions.
ICE, immunocapture ELISA.
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In shed no. 2, only three WALL goats displayed
some mild clinical signs during the study. One died
in the second week but the others recovered. Virus
identiﬁcation by ICE provided conﬁrmation of the
presence of PPRV in nine animals during the 4 weeks
of examination although only three of them showed
clinical signs. PPRV excretion was detectable in two
animals on the ﬁrst day of examination, and most of
the remainder during the second week. Antigen was
not detectable after 3 weeks of infection. The sero-
logical survey of the whole group also demonstrated
a low, but substantial response against PPRV.
However, one of the animals, which displayed clinical
signs, did not seroconvert (no. 578) (see Table 2). The
overall prevalence of antibodies to PPRV reached
56.7% (17/30) by the end of the experiment, suggest-
ing that there were many more infected animals than
those exhibiting clinical signs.
PPR infection and heterologous vaccination
Serum samples from goats were also tested for anti-
bodies against RPV by C-ELISA, and these results
are shown in Table 3. Seroconversion to RP occurred
2 weeks after vaccination as has been described pre-
viously [1, 11]. At the end of the experiment (day 22)
four WAD goats (36.4%) and 11 WALL goats
(36.7%) had seroconverted. As the animals were
Table 2. Disease status and PPR C-ELISA results from WALL goats excreting virus
Goat
no.
Disease
status
ICE* PPR C-ELISA
Day 1 Day 7 Day 14 Day 22 Day 1 Day 7 Day 14 Day 22
563 ND + x x x + + + +
564 ND x x + x x x + +
568 ND x + x x x x + +
574 ND x + x x x + + +
578 D x +D + x x xD x x
584 ND x + x x x + + +
597 D x x +D x x x +D +
599 ND x + x x x x + +
600 D +D +# d d +D d d d
ICE, immunocapture ELISA.
ND, not diseased ; D, diseased;+, animal detected positive ; d, died.
* Detection of nucleoprotein in nasal secretions.
# Post-mortem sample.
Table 3. Serological results of the interaction between PPR infection and
RP vaccination
Shed
no. Day
No. of
animals
surviving
Rinderpest seroconversion
Total (%)
With PPR
antibodies
Without PPR
antibodies
1 1 25 0 (0) 0/24 0/1
7 17 0 (0) 0/17 0/0
14 15 4 (26.7) 4/15 0/0
22 11 4 (36.4) 4/11 0/0
2 1 31 0 (0) 0/9 0/22
7 30 0 (0) 0/10 0/20
14 30 5 (16.7) 2/17 3/13
22 30 11 (36.7) 3/17 8/13
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immunized with RP vaccine during the outbreak of
PPR, the development of the vaccinal response in
individuals was also a function of previous immunity
against PPR. Among goats which had PPR antibodies
prior to vaccination, 18.8% (6/32) and 25.0% (7/28)
seroconverted to RP on days 14 and 22 respectively.
In contrast, among goats which had no PPR anti-
bodies, 23.1% (3/13) and 61.5% (8/13) seroconverted
on the same day after vaccination.
Sensitivity and speciﬁcity of ICE
The ICE test was used to conﬁrm cases of PPR sus-
pected on clinical grounds. At the time of discovery of
the disease, 26 out of 56 animals were sick, and 33
already had PPR antibodies (most from shed no. 1;
Table 1). There were 23 ICE-positive samples out of
56 tested, 22 were from diseased animals and one
from a healthy animal. The association of disease and
antigen detection was highly signiﬁcant (P=0.005).
Deﬁning clinical disease as the reference for the clini-
cal diagnosis of PPR, the ICE response rate (Table 4)
reached a sensitivity of 84.6% and a speciﬁcity of
96.7%. Compared to seroconversion, the ICE test
had only a positive predictive value of 65.6% sug-
gesting the 34.4% seropositive animals were not
detected by ICE. The negative predictive value, how-
ever, reached 91.7%.
The ICE test was also used to monitor the vacci-
natedWALL goats over 4 weeks. In this group, only 3
out of 31 animals were sick, and many seroconverted
without being sick (Tables 1 and 2). Overall, there
were 10 ICE-positive results out of 121 samples
tested: three were from diseased animals and seven
from healthy animals. No signiﬁcant association
could be made between shedding of antigen and dis-
ease (P>0.05). When compared to disease or sero-
conversion (Table 4), the sensitivity of the ICE test
was 100 and 11.5% respectively, while the speciﬁcity
was 94.1 and 94.2% respectively. In this group, the
test was positive for every clinical case, but ICE
had a poor positive predictive value for seropositive
animals : 88.5% of animals negative by ICE sero-
converted, and most of these animals did not show
any clinical signs of disease. However, the test had
a good negative predictive value (94.2%) for sero-
negative animals.
Cross-reactivity of the ICE test with other antigens,
especially RPV, was not expected [8]. However a
double-positive sample (nasal swab) was obtained
with the ICE test for animal no. 597 on day 14.
DISCUSSION
PPR has major economic consequences for sheep and
goat farming, owing to the highly contagious nature
and the rapid spread of the disease. Around 800 mil-
lion animals are estimated to be susceptible in coun-
tries which report the presence of the disease [12].
Indeed PPR, originally thought to be conﬁned to
West Africa, is widely distributed in sub-Saharan
Table 4. ICE ELISA test results on samples obtained from goats during the PPR outbreak
Positive ICE response/total
Conﬁrmation Monitoring
Results of disease status and seroconversion
Disease positive, seroconversion positive 21/25 2/2
Disease positive, seroconversion negative 1/1 1/1
Disease negative, seroconversion positive 0/7 4/50
Disease negative, seroconversion negative 1/23 3/68
Total 23/56 10/121
x2=7.813, P=0.005 x2=0.019, P=0.891
Sensitivity
vs. disease 22/26 (84.6) 3/3 (100)
vs. seroconversion 21/32 (65.6) 6/52 (11.5)
Speciﬁcity
vs. disease 29/30 (96.7) 111/118 (94.1)
vs. seroconversion 22/23 (95.7) 65/69 (94.2)
ICE, immunocapture ELISA.
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Africa, the Middle East and the Indian subcontinent
[4, 13–19]. Serological surveys have shown high
prevalences of antibodies against PPRV in small
ruminants in African countries [20, 21], but only few
studies of the pathogenicity of PPRV in goats under
natural or experimental conditions have been pub-
lished thus far [15, 17, 19].
From observing a PPR outbreak in two diﬀerent
breeds of goats, we found that the acute form of
the disease aﬀected WAD goats while WALL goats
developed only the milder form. This diﬀerence in
sensitivity to disease seems most likely to be related
to the breed and not to the virus. PPR viruses
from Africa and Asia are found to group in four
distinct lineages [18] (A. Diallo, personal communi-
cation), and WAD goats have recently been shown
to be extremely sensitive to PPRV whatever the
virus lineage involved (E. Couacy, personal com-
munication). Viruses isolated from western Africa,
including the isolate described in this report, form
lineage I.
During the PPR outbreak, good antibody re-
sponses against PPRV were provoked in both goat
breeds. However the value of vaccination during the
risk of infection, in this case with the heterologous
vaccine, was tested. A poor but eﬀective response
(37%) against RP vaccine was obtained with a zero
to moderate (31.6%) increase of immunity coverage
deﬁned by the combination of antibodies against both
RPV and PPRV. A total of 75% of the animals,
which had developed cross-neutralizing antibodies
against PPRV, did not respond to RP vaccine. This
supports data from a previous ﬁeld trial where the
unusually low response to RP vaccination of cattle,
sheep and goats was explained by the presence of
antibodies against PPRV before vaccination [20].
However, in this study almost all animals (96–100%)
which failed to respond to RP vaccine were found
to be PPR positive. Kulkarni and others [17] also
reported that for goats, the protection conferred by
RP tissue culture vaccine to a population at risk
might only be partial. This incomplete coverage of
the population, or possibly faulty vaccination proce-
dures, resulted in PPR outbreaks within a few
months of RP vaccination. However, heterologous
vaccination is known to protect small ruminants
against PPR for at least 12 months [3]. Although
described here for small ruminants, these observa-
tions can be transposed to cattle. Indeed, possible
experimental transmission of PPRV from sheep and
goats to cattle [22] as well as serological evidence
of the circulation of the virus [20, 23], need to be
taken into consideration when applying and evalu-
ating the RP control programmes in PPR endemic
areas.
An association of shedding of PPRV and acute or
mild clinical signs of the disease was seen in the pre-
sent study. The results obtained on 56 animals tested
during the outbreak showed that ICE ELISA, an
antigen detection test for the nucleoprotein of PPRV
and RPV, enabled early and direct demonstration of
the presence of PPRV in nasal secretions and in post-
mortem specimens: between 85 and 100% of speci-
mens from clinically infected goats were positive in
this assay. For RP the severity of the clinical signs is
correlated with the abundance of viral antigen in
lymphatic organs and the mucosae along the digestive
tract. It is likely that the same is true for PPRV.
However, even in animals that had only mild disease,
the rate of antigen positivity was quite high, demon-
strating the good sensitivity of the ICE test. For the
WALL goat population, a peak of excretion could be
detected at 1 week post-infection, before the rise of
antibodies at 14 days.
The poor sensitivity of the test (11.5%) compared
to seroconversion, however, suggests that during the
recovery period the infected animals are unlikely to be
detected by antigen detection procedures.
In this study, ICE did not usually detect the RPV
vaccine in secretions. This is probably because in los-
ing its virulence, the RPV vaccine strain loses its epi-
thelial tropism [24, 25]. Therefore, it is interesting to
speculate that the one RPV-positive animal arose
from RPV-infected lymphoid cells inﬁltrating the
epithelium. Indeed the PPR-infected animal no. 597
was showing signs of the disease.
The relative speciﬁcity estimates of the test sug-
gested that 3.3–8.3% of goats with no serological or
clinical sign of the disease would have detectable
amounts of virus in their nasal secretions. It is
believed that these subclinically infected animals can
initiate or perpetuate the infection in susceptible ani-
mals when introduced in a new herd. For these rea-
sons, disease control procedures must be used on
infected as well as on suspected herds.
Epidemiological interactions of PPR and RP
infections and/or vaccination in domestic ruminants
occurring in Africa and Asia need to be better
understood. The routine application of direct and
individual antigen detection using an immunocapture
test accompanied by the serological conﬁrmation
oﬀers new prospects for controlling PPRV.
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